Tibes, Raoul <br/><br/>
JAK inhibition: the key to treating myeloproliferative neoplasm?  [electronic resource] 

 -  Expert review of hematology  Dec 2012 
 - 583-5 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1747-4094 
<br/><br/><label>Standard No.: </label>10.1586/ehm.12.55  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Marrow Neoplasms--drug therapy<br/>Humans<br/>Janus Kinase 2--antagonists & inhibitors<br/>Myeloproliferative Disorders--drug therapy<br/>Nitriles<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrazoles--therapeutic use<br/>Pyrimidines<br/>Quality of Life